BBK Worldwide
announces the debut of DocManager v2SM–a technological initiative developed in direct response to industry demand for secure, web-based systems solely devoted to managing timely and cost-efficient translation, regulatory approvals, and distribution of patient recruitment and retention materials around the world.
The task of managing translations and securing regulatory approvals in every study country is often fraught with miscommunications and errors that lead to production delays and cost overruns. Aiding and abetting this problem is the fact that existing entities charged with managing ethics committee (EC) submissions relegate patient recruitment materials to the bottom of the queue, given their first priority of managing protocol approvals within a given country.
“The inability to predict, or govern, how long global ethics committees will take in the review process means that if you make one mistake along any step of the way, you can end up doubling or tripling the development time of materials for a given country, hindering patient recruitment efforts and delaying time-to-market,” said Matt Kibby, global operations leader for BBK Worldwide. “BBK is now in a position to not only develop, but also to take full accountability for EC submissions and tracking of patient recruitment materials, elevating its importance by eliminating the competitive forces that prevent the study community from attending to this critical task,” he added.
Through its patented methodology, DocManager v2 facilitates optimal workflow within a closed and secure web-based environment and ensures that documents are organized for various levels of review to avoid the common, time-consuming pitfalls that delay project implementations. Documents and materials are locked by DocManager v2 and cannot be distributed until final approvals are received through an inherent system of checks and balances. A document “check-out” feature keeps users aware if other colleagues are working on a given document. Meanwhile, date and time stamps facilitate accurate predictions of development timeframes to help to quickly address workflow problems. The intuitive interface of DocManager v2 also follows a “tree structure” familiar to users of the ubiquitous MS Windows® system of primary and subordinate virtual folders.
“It does all this using an intuitive drag-and-drop interface that facilitates user understanding of the flow of thousands of documents–so it actively teaches best operating procedures to everyone involved,” Kibby said.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.